Urol. praxi. 2023;24(4):229-234 | DOI: 10.36290/uro.2023.085

The risks of testosterone therapy

MUDr. Mgr. Magda Krechlerová, FEBU
Urologické oddělení FN u sv. Anny v Brně
Ústav ochrany a podpory zdraví LF MU v Brně

The main treatment for primary hypogonadism is testosterone replacement therapy. In urological outpatient practice, we often consult men with late onset hypogonadism due to aging. Regarding patients age and comorbidities knowledge of correct diagnostics, indications and forms of treatment is essential. The goal is torelive the symptoms of hypogonadism while maintaining maximal safety and minimalising the adverse effects of the treatment. The article summarizes knowledge about the physiological effect of testosterone, the benefits and risks of its substitution.

Keywords: hypogonadism, male aging syndrome, testosterone replacement.

Accepted: November 27, 2023; Published: November 30, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krechlerová M. The risks of testosterone therapy. Urol. praxi. 2023;24(4):229-234. doi: 10.36290/uro.2023.085.
Download citation

References

  1. Silernagl S, Despopoulos A. Hormony, reprodukce. In: Atlas fyziologie člověka. Praha: Grada; 2004:266-308.
  2. Silernagl S, Lang F. Příčiny a důsledky nadbytku nebo nedostatku androgenů. In: Atlas patofyziologie. Praha: Grada; 2012:294-295.
  3. Ganong WF. Gonády: vývoj a funkce reprodukčního systému. In: Ganong WF. Přehled lékařské fyziologie. H&H Jinočany. 1995:347-381.
  4. Zámečník L, et al. Hormonální prostředí muže, aging male - syndrom mužského stárnutí a hormonální terapie. In: Praktická andrologie dospělých. Praha: Mladá fronta; 2010.
  5. Guidelines on Sexual and Reproductive Health. In: EAU Guidelinies 2023:17-36.
  6. Herrmann F, Múller P, Lohmann T. Endokrinologie pro praxi. Diagnostika a léčba od A do Z. Praha: Grada; 2020.
  7. Stárka L, Zamrazil V. Endokrinně podmíněná onemocnění gonád. In: Základy klinické endokrinologie. Praha: Maxdorf; 2005.
  8. Kawaciuk I. Andrologie. In: Urologie. Praha: Galén; 2009.
  9. Zámečník L, Macek P. Androgenní deficit u mužů. In: Moderní farmakologie v urologii. Praha: Maxdorf; 2012.
  10. Kubíček V. Výhody a nevýhody substituční terapie testosteronem. Urol Praxi. 2008;9(6):287-290.
  11. Robert M., Davis AM. Evaluatin and Treatment of Male Hypogonadism. JAMA. 2018;319(13):1375-1376. Go to original source... Go to PubMed...
  12. Cheetham TC, An J, Jacobsen SJ, et al. Association of testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency. JAMA . Internal Med. 2017;177(4):491-499. Go to original source... Go to PubMed...
  13. Nora Ch, Meier ChA. Hypotestosteronaemia in the aging male: shoud we treat it? Swiss Med Wkly. 2015;145:w14216.
  14. Roy CN, Snydle PJ, Stephens-Shields AJ. Association of Testosterone Levels With Anemia in Older Men. A controlled Clinical Trial. JAMA Intern. Med. 2017;177(4):480-490. Go to original source... Go to PubMed...
  15. Walker RF, Zakai NA, MacLehose RF, et al. Association of Testosterone Therapy With Risk of Venous Tromembolism Among Men With and Without Hypogonadism. JAMA Intern.Med. 2020;180(2):190-197. Go to original source... Go to PubMed...
  16. Emmelot-Vonk ME, Verhaar HJJ, Nakhai Pour HR, et al. Effect of Testosterone. Supplementation on Functional Moblity, Cognition and Other Parametrs in Older Men. A Randomized Controlled Study. JAMA. 2008;299(1):39-52. Go to original source... Go to PubMed...
  17. Snyder PJ, Kopperdahl DL, Stephens-Shields AJ. Effect of Testosterone on Volumetric Bone Density and Strength in Older Men With Low Testosterone. A controlled Clinical Trial. JAMA Intern. Med. 2017;177(4):471-479. Go to original source... Go to PubMed...
  18. Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of depressive symptoms in Men. A systematic Review and Meta-analysis. JAMA Psychiatry. 2019;76(1):31-40. Go to original source... Go to PubMed...
  19. Resnick SM, Matsumoto AM, Hield AJ. Testosterone Treatment an Cognitve Function in Older Men With Low Testosterone and Age-Associated Memory Impairment. JAMA. 2017;317(7):717-727. Go to original source... Go to PubMed...
  20. Budoff MJ, Ellenberg SS, Lewis C, et al. Testosteron Treatment and Coronary Artery Plaque Volume in Older Men with Low Testostreone. JAMA. 2017;317(7):708-716. Go to original source... Go to PubMed...
  21. Layton JB, Meier ChR, Shrapless JL, et al. Comparative Safety of Testosterone Dosage Forms. JAMA Intern.Med. 2015;175(7):1187-1196. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.